Literature DB >> 16132575

Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer.

Michael I Koukourakis1, Alexandra Giatromanolaki, Costantinos Simopoulos, Alexandros Polychronidis, Efthimios Sivridis.   

Abstract

Lactate dehydrogenase 5 (LDH5) is one of the five LDH isoenzymes and, apparently, the most important for promoting anaerobic glycolysis. LDH5 is transcriptionally regulated by the hypoxia inducible factors (HIF) 1alpha and 2alpha. In this study, the possible aggressive advantages that colorectal tumours may gain from a high LDH5 content was investigated. To this end, 75 colorectal adenocarcinomas were studied immunohistochemically for the expression of LDH5, and the results were related to tumor differentiation, lymph node and distant metastases, the expression of HIF1alpha and HIF2alpha, vascular density (VD) and vascular endothelial growth factor (VEGF). A high LDH5 content was noted in 51 of 75 (68%) colorectal adenocarcinomas. The reactivity was nuclear and/or cytoplasmic. Nuclear LDH5 reactivity was correlated with lymph node involvement and distant metastases. There was a direct association between LDH5 up-regulation and HIF1alpha and HIF2alpha accumulation. HIF1alpha was linked with VEGF, VD and also with extramural invasion, nodal and distant metastases. It is concluded that a high LDH5 content in tumor cells is directly related to an up-regulated HIF pathway and is linked with an aggressive phenotype in colorectal adenocarcinomas.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132575     DOI: 10.1007/s10585-005-2343-7

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  28 in total

1.  On the origin of cancer cells.

Authors:  O WARBURG
Journal:  Science       Date:  1956-02-24       Impact factor: 47.728

Review 2.  Causes and consequences of tumour acidity and implications for treatment.

Authors:  M Stubbs; P M McSheehy; J R Griffiths; C L Bashford
Journal:  Mol Med Today       Date:  2000-01

3.  Prognostic features and treatment outcome in locoregionally advanced nasopharyngeal carcinoma following concurrent chemotherapy and radiotherapy.

Authors:  S H Cheng; J J Jian; S Y Tsai; K Y Chan; L K Yen; N M Chu; T D Tan; M H Tsou; A T Huang
Journal:  Int J Radiat Oncol Biol Phys       Date:  1998-07-01       Impact factor: 7.038

4.  Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer.

Authors:  F Tas; A Aydiner; C Demir; E Topuz
Journal:  Am J Clin Oncol       Date:  2001-08       Impact factor: 2.339

5.  Acidosis protects against lethal oxidative injury of liver sinusoidal endothelial cells.

Authors:  S F Bronk; G J Gores
Journal:  Hepatology       Date:  1991-07       Impact factor: 17.425

6.  Protection from oxidative stress-induced apoptosis in cortical neuronal cultures by iron chelators is associated with enhanced DNA binding of hypoxia-inducible factor-1 and ATF-1/CREB and increased expression of glycolytic enzymes, p21(waf1/cip1), and erythropoietin.

Authors:  K Zaman; H Ryu; D Hall; K O'Donovan; K I Lin; M P Miller; J C Marquis; J M Baraban; G L Semenza; R R Ratan
Journal:  J Neurosci       Date:  1999-11-15       Impact factor: 6.167

7.  Role for mitochondrial oxidants as regulators of cellular metabolism.

Authors:  S Nemoto; K Takeda; Z X Yu; V J Ferrans; T Finkel
Journal:  Mol Cell Biol       Date:  2000-10       Impact factor: 4.272

8.  Hypoxic regulation of lactate dehydrogenase A. Interaction between hypoxia-inducible factor 1 and cAMP response elements.

Authors:  J D Firth; B L Ebert; P J Ratcliffe
Journal:  J Biol Chem       Date:  1995-09-08       Impact factor: 5.157

9.  Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1.

Authors:  G L Semenza; B H Jiang; S W Leung; R Passantino; J P Concordet; P Maire; A Giallongo
Journal:  J Biol Chem       Date:  1996-12-20       Impact factor: 5.157

10.  Lactate dehydrogenase-5 (LDH-5) overexpression in non-small-cell lung cancer tissues is linked to tumour hypoxia, angiogenic factor production and poor prognosis.

Authors:  M I Koukourakis; A Giatromanolaki; E Sivridis; G Bougioukas; V Didilis; K C Gatter; A L Harris
Journal:  Br J Cancer       Date:  2003-09-01       Impact factor: 7.640

View more
  86 in total

Review 1.  Targeting lactate metabolism for cancer therapeutics.

Authors:  Joanne R Doherty; John L Cleveland
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

2.  Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA.

Authors:  Aik T Ooi; Brigitte N Gomperts
Journal:  Clin Cancer Res       Date:  2015-04-02       Impact factor: 12.531

Review 3.  Antiangiogenic therapy in human gastrointestinal malignancies.

Authors:  J Heidemann; D G Binion; W Domschke; T Kucharzik
Journal:  Gut       Date:  2006-10       Impact factor: 23.059

4.  Bone marrow angiogenesis in patients presenting with differential Chinese medicine syndrome: correlation with the clinico-pathological features of aplastic anemia.

Authors:  Di-jiong Wu; Bao-dong Ye; Zhi-ping Hu; Yi-ping Shen; Jian-ping Shen; Sheng-yun Lin; Ming-tao Chen; Yong-lin Liu; Yu-hong Zhou
Journal:  Chin J Integr Med       Date:  2013-12-05       Impact factor: 1.978

Review 5.  Small-molecule inhibitors of human LDH5.

Authors:  Carlotta Granchi; Ilaria Paterni; Reshma Rani; Filippo Minutolo
Journal:  Future Med Chem       Date:  2013-10       Impact factor: 3.808

6.  Screening of novel inhibitors targeting lactate dehydrogenase A via four molecular docking strategies and dynamics simulations.

Authors:  Rong Sun; Xin Li; Yuanyuan Li; Xun Zhang; Xinru Li; Xiaoyu Li; Zheng Shi; Jinku Bao
Journal:  J Mol Model       Date:  2015-05-02       Impact factor: 1.810

Review 7.  New approaches in angiogenic targeting for colorectal cancer.

Authors:  Aleix Prat; Esther Casado; Javier Cortés
Journal:  World J Gastroenterol       Date:  2007-11-28       Impact factor: 5.742

8.  Involvement of hypoxia-inducing factor-1alpha-dependent plasminogen activator inhibitor-1 up-regulation in Cyr61/CCN1-induced gastric cancer cell invasion.

Authors:  Ming-Tsan Lin; I-Hsin Kuo; Cheng-Chi Chang; Chia-Yu Chu; Hsing-Yu Chen; Been-Ren Lin; Munisamy Sureshbabu; Hou-Jung Shih; Min-Liang Kuo
Journal:  J Biol Chem       Date:  2008-04-01       Impact factor: 5.157

9.  Glucose transporter 1 (GLUT1) of anaerobic glycolysis as predictive and prognostic values in neoadjuvant chemoradiotherapy and laparoscopic surgery for locally advanced rectal cancer.

Authors:  Byoung Yong Shim; Ji-Han Jung; Kang-Moon Lee; Hyung-Jin Kim; Sook Hee Hong; Sung Hwan Kim; Der Sheng Sun; Hyeon-Min Cho
Journal:  Int J Colorectal Dis       Date:  2012-07-31       Impact factor: 2.571

10.  Equating salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into metabolic reprogramming of cancer cell as a predictor of aggressive phenotype.

Authors:  Tajindra Singh Saluja; Anita Spadigam; Anita Dhupar; Shaheen Syed
Journal:  Tumour Biol       Date:  2015-11-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.